On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
ThursdayOct 05, 2017 11:07 am

Emblem Corp. (TSX.V: EMC) (OTC: EMMBF) Enters Agreement for Sustained Release Cannabinoid Formulation

Companies collaborating on development of patent-pending sustained release oral cannabinoid formulation Formulation doubles or triples time period in which cannabinoid doses maintain their therapeutic effects Formulation enables better regulation of dosing schedules and improvement of patient compliance Emblem Corp. (TSX.V: EMC) (OTC: EMMBF), a company licensed to cultivate and sell medical marijuana in Canada under the Access to Cannabis for Medical Purposes Regulations, has entered into a collaboration and licensing agreement with Canntab Therapeutics Limited to collaborate on the preclinical formulation, clinical development, regulatory approval, manufacturing and commercialization of Canntab’s patent-pending oral sustained release formulation for cannabinoids. Through this agreement,…

Continue Reading

ThursdayOct 05, 2017 10:12 am

Marijuana Company of America, Inc. (MCOA) is “One to Watch”

Strategic approach to cannabis and hemp industry through networking architecture Legal marijuana markets estimated to reach $22.6 billion by 2021 Branded “hempSMART Brain™” CBD product is first to be offered by direct market Wellness industry is now $1.9 trillion per year with huge growth potential The founders of Marijuana Company of America, Inc. (OTC: MCOA) (the “Company”) are pioneers in the cannabis industry going back to 2009 when Don Steinberg, MCOA’s CEO, founded the first marijuana company ever to trade on a US stock market, Medical Marijuana Inc. Since then, Don and his partner, Charlie Larsen, have formed Global Hemp…

Continue Reading

ThursdayOct 05, 2017 9:30 am

Grey Cloak Tech, Inc. (GRCK) to Enter Medical Practitioner Market through Planned Purchase of Eqova Life Sciences

Acquisition provides GRCK with an entry into the CBD market Eqova is fully-focused on providing hemp oil health products to partners in the medical practitioner market and plans to dominate that niche The CBD market is seen growing 700% to $2.1 billion by 2020, according to The Hemp Business Journal Grey Cloak Tech, Inc.’s (OTC: GRCK) signing of a binding letter of intent to purchase CBD company Eqova Life Sciences is expected to enable it to enter the medical practitioner market (http://cnw.fm/b1ZGg). Eqova is a company that's focused exclusively on offering a full spectrum line of clinical-grade hemp oil products…

Continue Reading

ThursdayOct 05, 2017 9:30 am

SinglePoint, Inc. (SING) – An Evolutionary Success Tale

Diversified portfolio for sustainable growth offers multiple revenue options Entry into legalized cannabis market continues with acquisition of multiple cannabis companies Ancillary cannabis-related businesses poised to reap healthy portion of multi-billion-dollar industry SinglePoint, Inc. (OTC: SING) has evolved from a full-service provider of mobile technology to a publicly traded holding company focused on diversifying into horizontal markets that offer multiple revenue streams for investors. Key to this approach is SinglePoint’s strategic expansion into the burgeoning legal marijuana industry, which includes the acquisition of several important cannabis-related brands. Projected growth estimates for the legal marijuana industry continue to brighten the mood…

Continue Reading

WednesdayOct 04, 2017 2:23 pm

PotNetwork Holding Inc. (POTN) in the Midst of a 700% Upsurge Market

CBD market estimated to grow by 700% by 2020 POTN has scientific focus on quality and therapeutic consistency POTN multiple product lines and global distribution Positioned for outsized share of the growth It’s no wonder that medicinal marijuana, cannabis and hemp (cannabidiol) has become a veritable gold rush given the 700% market upsurge projected over the next three years (http://cnw.fm/A4otO). Millions of people currently use cannabis, including CBD products, for medical therapies to treat pain, epilepsy, depression and multiple other maladies according to many abstracts and studies available from the U.S. National Library of Medicine National Institutes of Health.  From…

Continue Reading

TuesdayOct 03, 2017 9:00 am

Cannabis Market Extends across Numerous Industry Segments

CannabisNewsWire Editorial Coverage: Growth has been the dominant theme in the cannabis market. Estimates by Forbes put the legal cannabis market at a value of $7.2 billion (per a February 2017 report), and the market is expected to generate more jobs than government, manufacturing, or utilities in the coming years, according to the Bureau of Labor Statistics. Numerous industries are being impacted. Cultivation and medicine are just a couple of examples, but cannabis is showing a strong presence in the retail, consulting, and consumer sectors. SinglePoint, Inc. (SING) (SING Profile) has focused on business development in multiple segments thanks to…

Continue Reading

MondayOct 02, 2017 12:24 pm

Algae Dynamics Corp. (ADYNF) Research Efforts Focus on Healthier Benefits of Cannabis Oils

Health conscious consumers favor cannabis oil extracts and edibles over smoking Recent survey shows 46% of Canadians would try cannabis-infused products Canadian cannabis oil extraction market expected to reach $1.7 billion by 2020 Algae Dynamics Corp (OTC: ADYNF) is uniquely positioned to benefit from the upcoming legalization of recreational marijuana in Canada by mid-2018. The company’s focus on developing proprietary research and products involving botanical oils derived from cannabis combines two important consumer demands – the well-known health benefits of cannabinoids and a smoke-free alternative to cannabis consumption. Nearly half of Canadians (46%) polled in August 2017 by Dalhousie University…

Continue Reading

MondayOct 02, 2017 11:25 am

India Globalization Capital, Inc. (NYSE: IGC) to Launch Medical Dispensary Product for Alzheimer’s Disease

Product portfolio to include drugs and supplements Faster monetization of lead Alzheimer’s candidate as supplement Market valuation poised to soar It should come as no surprise to discover that the medical cannabis dispensary product line in America is getting increasingly diverse and sophisticated. After all, the cannabis sativa plant incorporates over 400 chemical entities, of which more than 60 are cannabinoids. Even though cannabis has been used and cultivated by mankind for at least 6,000 years, it was only relatively recently, in 1899, that the first cannabinoid, cannabinol (CBN), was identified and isolated. With so much chemistry wrapped in its…

Continue Reading

MondayOct 02, 2017 9:54 am

PotNetwork Holding, Inc. (POTN) Projected to Reach Greater than $30 Million in Revenues in FY2019, Per SeeThruEquity

In July 2017, POTN had a 30% jump in sales to nearly $1.5 million versus June 2017 Research report estimates $8.4 million in revenues in FY2017 and notes POTN plans for international expansion, with initial focus on China Aggressive marketing strategy and branding means more POTN sales and retail placement from increased exposure at trade and sporting events PotNetwork Holding, Inc. (OTC: POTN) revenues are projected to reach greater than $30 million by FY2019, $16.7 million in FY2018 and $8.4 million this fiscal year, according to SeeThruEquity, LLC (http://cnw.fm/QSUd2). POTN is a holding company for subsidiary First Capital Venture Co.,…

Continue Reading

FridaySep 29, 2017 12:52 pm

Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) Tech Discussed at “Cannabis in the Capital Markets” Event

Clinical studies of TurboCBD™ a topic of discussion at Canadian Securities Exchange-sponsored “Cannabis in the Capital Markets” event Patents cover variety of lipophilic bio-actives, including cannabinoids, nicotine and vitamins Growing portfolio of intellectual property includes 19 patents filed across 44 countries Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP), through its proprietary technology for delivering bioactive compounds in lipid formulations, offers licensed partners the ability to include cannabidiol (CBD) in a variety of ingestible products appropriate for medical patients and recreational users alike. In a new report, Grand View Research, Inc., states that the global market for medical cannabis alone is…

Continue Reading

Contact us: 303.498.7722